Form 4 for SNTI Senti Biosciences Holdings, Inc.
Accepted 2024-02-02 00:00:00 ET · period of report 2024-02-01 · accession 0001854270-24-000017 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-02 | 2024-02-01 | SNTI | Rajangam Kanya | Chief Medical, Devt. Off | A - Grant | $0.00 | +101.0K | 101.0K | New | $0 |
| D | 2024-02-02 | 2024-02-01 | SNTI | Rajangam Kanya | Chief Medical, Devt. Off | A - Grant | $0.00 | +152.0K | 152.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-01 | A | A | 101,000 | $0.00 | 101,000 | D | — | — | (F1) The shares reported in this transaction represent restricted stock units ("RSUs") issued under the Senti Biosciences, Inc. 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. All of the shares underlying the award vest in three substantially equal annual installments over three years from February 1, 2024, subject to the reporting person's continued service through the applicable vesting date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-02-01 | A | A | 152,000 | $0.00 | 152,000 | D | $0.46 · — to 2034-01-31 | 152,000 Common Stock | (F2) The shares underlying this option vest in 48 substantially equal monthly installments over four years from February 1, 2024, subject to the reporting person's continued service through the applicable vesting date. |